文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

ICU中支气管念珠菌定植对细菌性呼吸机相关性肺炎风险的影响:FUNGIBACT前瞻性队列研究

Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study.
PubMed 文献 · Intensive Care Med · 2019-04-24
一句话结论机械通气超过4天且多器官衰竭患者中,支气管念珠菌定植与细菌性VAP无关联(调整后病因特异HR=0.98,p=0.95)。

FUNGIBACT前瞻性队列研究纳入2012-2015年机械通气超过4天且多器官衰竭患者213例(中位年龄64岁,SAPS II 55,SOFA 10,92%为内科原因收入),在D0及每4天评估气管念珠菌定植,并在每次VAP发作时行近端和气管定量培养。146例(68.5%)存在气管念珠菌定植;62例(29.1%)在D0后中位5.5天发生首次或唯一一次VAP,12例(5.6%)在D0后中位15.5天发生第二次VAP。采用病因特异模型校正时间依赖混杂因素和免疫因素后,念珠菌支气管定植与VAP无关联(调整后病因特异风险比=0.98,95%CI 0.59-1.65,p=0.95)。

要点

  • 机械通气超过4天且多器官衰竭患者中,68.5%(146/213)存在气管念珠菌定植。
  • 校正时间依赖混杂因素和免疫因素后,念珠菌定植与细菌性VAP无关联(调整后病因特异HR=0.98,95%CI 0.59-1.65,p=0.95)。
  • 29.1%(62例)发生首次或唯一一次VAP,中位时间D0后5.5天;5.6%(12例)发生第二次VAP,中位时间D0后15.5天。
  • 中位ICU住院24天,死亡率32%(69例)。

适用人群与场景

  • 机械通气超过4天且存在多器官衰竭的患者;2012-2015年纳入213例,中位年龄64岁,SAPS II 55,SOFA 10,主要因内科原因收入(197例,92%)。

诊断标准与关键阈值

  • 在纳入时(第0天,D0)及每4天至拔管评估气管念珠菌定植;每次VAP发作时行近端和气管定量培养。
  • D0和D7检测单核细胞人类白细胞抗原-DR同种型(mHLA-DR)表达及多形核白细胞与淋巴细胞比值以评估免疫麻痹。

研究设计与关键结果

  • 前瞻性队列研究(FUNGIBACT),纳入机械通气超过4天且多器官衰竭患者213例,2012-2015年入组;中位ICU住院24天,死亡率32%(69例)。
  • 中位mHLA-DR为5916抗体结合/细胞[3863-8934];中位淋巴细胞计数0.9Giga/L[0.6-1.3];中性粒细胞与淋巴细胞比值10.9[6.5-19.7]。
  • 146例(68.5%)存在气管念珠菌定植;62例(29.1%)在D0后中位5.5天发生首次或唯一一次VAP,12例(5.6%)在D0后中位15.5天发生第二次VAP。
  • 校正时间依赖混杂因素和免疫因素后,念珠菌支气管定植与VAP无关联(调整后病因特异风险比=0.98,95%CI 0.59-1.65,p=0.95)。

证据类型、等级与局限

  • 前瞻性队列研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在机械通气超过4天且多器官衰竭的患者中,支气管念珠菌定植与VAP无关联,即使校正免疫功能后亦然。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Respiratory tract Candida spp. colonization is associated with more frequent bacterial ventilator-associated pneumonia (VAP). However, this colonization could be causally related to VAP or simply reflect the immune paralysis associated with multiple organ failure.

OBJECTIVE: To prospectively evaluate the relationship between Candida spp. colonization and bacterial VAP in mechanically ventilated patients with multiple organ failure.

INCLUSION: Patients receiving mechanical ventilation for > 4 days and presenting multiple organ failure were included. Tracheal colonization with Candida spp. was evaluated at inclusion (day 0, D0) and every 4 days until extubation. Quantitative proximal and tracheal cultures were performed at each VAP episode. Monocyte human leukocyte antigen-DR isotype (mHLA-DR) expression and the ratio of polymononuclear leukocytes to lymphocytes were used to evaluate immunoparalysis at D0 and D7. The relationship between fungal colonization and VAP was modelled using cause-specific models for repeated events with adjustment for time-dependent confounders and immune factors.

RESULTS: A total of 213 patients, with a median age of 64, simplified acute physiology score II (SAPS II) score 55 and sequential organ failure assessment (SOFA) score 10, mainly admitted for medical reasons (n = 197, 92%), were enrolled in 2012-2015. The median ICU stay was 24 days and the mortality rate was 32% (69 cases). Median mHLA-DR was 5916 Ab-bound/cell [3863-8934]; median lymphocyte count, 0.9Giga/L [0.6-1.3]; neutrophil-to-lymphocyte ratio, 10.9 [6.5-19.7]. Overall, 146 cases (68.5%) had tracheal colonization with Candida spp. An episode of VAP occurred (either for the first or only time) in 62 (29.1%) cases 5.5 days (median) after D0; a second episode occurred in 12 (5.6%) cases, 15.5 days (median) after D0. After adjustment, bronchial colonization with Candida was not associated with VAP [adjusted cause-specific hazard ratio = 0.98 (0.59-1.65), p = 0.95].

CONCLUSION: In patients with mechanical ventilation for more than 4 days and multiple organ failure, bronchial colonization with Candida spp. was not associated with VAP, even after adjustment for immune function.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Timsit JF, Schwebel C, Styfalova L, et al. Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study. Intensive Care Med. 2019. PMID: 31020361. doi:10.1007/s00134-019-05622-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。